InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Janda Kim, Director. Insider active across 1 companies, notably Sorrento Therapeutics, Inc.. Aggregated, 6 filings have been published. The latest transaction was disclosed on 27 December 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€10,5973,000 shares@ €3.532212.0% of flow
Common Stock
SEC:0001209191-21-071311·
€10,5973,000 shares@ €3.53220.0025% mcap6.0% of flow
Common Stock
SEC:0001209191-21-071311:0·
€53,86135,000 shares@ €1.538961.1% of flow
Common Stock
SEC:0001209191-21-057957·
€53,86135,000 shares@ €1.53890.013% mcap30.5% of flow
Common Stock
SEC:0001209191-21-057957:0·
€23,7058,000 shares@ €2.963126.9% of flow
Common Stock
SEC:0001209191-21-055954·
€23,7058,000 shares@ €2.96310.0057% mcap13.4% of flow
Common Stock
SEC:0001209191-21-055954:0·
6 of 6 declarations
About Janda Kim
Janda Kim is a Board Member at Sorrento Therapeutics, Inc. In this role, she participates in overseeing the company's activities and making strategic decisions. Kim brings her expertise to guide the direction of Sorrento and ensure compliance with governance standards. Her commitment to operational excellence is a valuable asset to the board.
